A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 1202.
Kuyama S, Ochi N, Bessho A, Hotta K, Ikeda G, Kishino D, Kubo T, Harada D, Fujimoto N, Nakanishi M, Umeno T, Okada T, Chikamori K, Yamagishi T, Ohashi K, Ichihara E, Takigawa N, Tanimoto M, Kiura K.
Kuyama S, et al. Among authors: takigawa n.
Lung Cancer. 2017 Oct;112:188-194. doi: 10.1016/j.lungcan.2017.08.010. Epub 2017 Aug 12.
Lung Cancer. 2017.
PMID: 29191594
Clinical Trial.